Edwards Lifesciences Corp
XBER:EWL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Edwards Lifesciences Corp
XBER:EWL
|
US |
|
DSV A/S
CSE:DSV
|
DK |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
S
|
Swiss Re AG
LSE:0QL6
|
CH |
|
H
|
Heineken Holding NV
F:4H5
|
NL |
|
S
|
State Bank of India
LSE:SBID
|
IN |
|
Young & Co's Brewery PLC
F:YBY
|
UK |
|
P
|
Pan American Silver Corp
SWB:PA2
|
CA |
|
D
|
Discovery Ltd
JSE:DSBP
|
ZA |
|
A
|
AMETEK Inc
SWB:AK1
|
US |
|
Pearson PLC
LSE:PSON
|
UK |
|
O
|
Oracle Corp
XMUN:ORC
|
US |
|
T
|
TAG Immobilien AG
OTC:TAGYY
|
DE |
|
E
|
Eaton Corporation PLC
DUS:3EC
|
IE |
|
Mitsubishi Electric Corp
LSE:MEL
|
JP |
Wall St Price Targets
EWL Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EWL is 80.14 EUR with a low forecast of 70.24 EUR and a high forecast of 94.5 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EWL's stock price target?
Price Target
80.14
EUR
According to Wall Street analysts, the average 1-year price target for EWL is 80.14 EUR with a low forecast of 70.24 EUR and a high forecast of 94.5 EUR.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 27%.
